Copyright
©The Author(s) 2025.
World J Diabetes. Feb 15, 2025; 16(2): 98423
Published online Feb 15, 2025. doi: 10.4239/wjd.v16.i2.98423
Published online Feb 15, 2025. doi: 10.4239/wjd.v16.i2.98423
Group | Number of patients (male/female) | Age (years) | BMI (kg/m2) | Smoking (n) | TC (mmol/L) | TG (mmol/L) | HDL-C (mmol/L) |
A | 160 (80/80) | 60.07 ± 10.47 | 25.1 ± 2.9 | 48 | 5.01 ± 1.11 | 1.64 ± 0.97 | 1.09 ± 0.46 |
B | 200 (100/100) | 61.40 ± 9.97 | 25.0 ± 3.1 | 60 | 4.69 ± 0.75b | 1.27 ± 0.60b | 1.18 ± 0.27 |
C | 60 (30/30) | 59.99 ± 10.32 | 25.2 ± 3.0 | 14 | 4.76 ± 1.12b | 1.29 ± 0.60b | 1.24 ± 0.28b |
Independent variables | β | Standard error | Wald | OR (95%CI) | P value |
Ki-67 | −0.140 | 0.045 | 9.697 | 0.870 (0.796–0.950) | 0.002 |
FPG | 0.654 | 0.234 | 7.810 | 1.923 (1.216–3.043) | 0.005 |
HbA1c | 1.452 | 0.690 | 15.036 | 11.563 (2.165-12.016) | < 0.01 |
Insulin | −0.126 | 0.057 | 4.880 | 0.882 (0.788–0.986) | 0.027 |
HDL-C | −3.151 | 1.151 | 7.495 | 0.043 (0.004–0.409) | 0.006 |
TC | 1.137 | 0.515 | 4.864 | 3.116 (1.135–8.556) | 0.027 |
TG | 0.054 | 0.405 | 0.018 | 1.056 (0.477–2.336) | 0.893 |
LDL-C | 0.377 | 0.381 | 0.978 | 1.458 (0.691–3.077) | 0.323 |
- Citation: Chen K, Wang G, Hu JC, Zhou YY, Ma HT. Clinical significance of Ki-67 in patients with lung adenocarcinoma in situ complicated by type 2 diabetes. World J Diabetes 2025; 16(2): 98423
- URL: https://www.wjgnet.com/1948-9358/full/v16/i2/98423.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i2.98423